🇺🇸 FDA
Pipeline program

Levetiracetam XR, Masked Keppra® placebo film-coated tablets (a placebo tablet inside a capsule), Keppra 500 mg film-coated tablets, Levetiracetam prolonged-release placebo granules

NXPLEVE/24/P3-6

Phase 3 small_molecule active

Quick answer

Levetiracetam XR, Masked Keppra® placebo film-coated tablets (a placebo tablet inside a capsule), Keppra 500 mg film-coated tablets, Levetiracetam prolonged-release placebo granules for Refractory Partial Onset Epilepsy is a Phase 3 program (small_molecule) at Neuraxpharm Pharmaceuticals S.L. with 1 ClinicalTrials.gov record(s).

Program details

Company
Neuraxpharm Pharmaceuticals S.L.
Indication
Refractory Partial Onset Epilepsy
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials